A new study suggests a surprisingly simple compound could help fight Alzheimer’s disease. Researchers found that arginine—an inexpensive amino acid already considered safe—can reduce the buildup of ...

Recognizing the signs of mild cognitive impairment meant Di could start treatment earlier to help slow her Alzheimer's ...

This is the second disease-slowing drug for Alzheimer’s that has been approved in Canada, after Health Canada approved ...

Drugs designed to clear amyloid beta from the brain—once seen as a promising path to slowing Alzheimer’s—may not actually ...

For decades, Alzheimer’s disease has been seen as a brain disorder caused by toxic protein buildup, but new research suggests ...

Scientists have uncovered a surprising overlap between cancer genetics and Alzheimer’s disease, involving mutations in the ...

Alzheimer's Disease," Cleveland Clinic behavioral neurologist Jagan Pillai, MD, PhD, and host Glenn Campbell continue their ...

From financial woes to a declining sense of smell, issues that seem unrelated to memory can signal a dementia diagnosis in ...

Health Canada has approved a second drug that targets the underlying cause of Alzheimer’s disease, a development that could ...

The FDA has approved Auvelity for treating agitation in patients with dementia due to Alzheimer’s disease, Axsome ...

Researchers at the Indiana University School of Medicine have developed a new way to read the brain's "energy network ...

Health Canada has approved a new once-monthly drug for people living with early symptomatic Alzheimer’s disease. Donanemab is intended to treat adults with a clinical diagnosis of mild cognitive ...